Rethinking Immunotherapy for Cancer: When Is the Best Time to Stop?
Wall Street Journal
Immune-boosting drugs extend cancer patients’ lives and deliver billions in sales to drugmakers, but some patients might be getting more of the drugs than they need.
https://www.wsj.com/articles/cancer-treatment-immunotherapy-drugs-328a9766